Insights On Drug Discovery

1. Top 8 Considerations For Choosing A PDX Model 10/7/2025

   To guide your decision-making, we’ve outlined the top 10 criteria to consider when evaluating PDX models for your next oncology research or drug development program.

2. TARGATT™ Rapid And Efficient Transgene Integration Technology: Stable Cell Line Development And Generation Of Large Mammalian Cell-Based Screening Libraries 10/3/2025

   TARGATT™ technology enables precise, efficient single-copy gene integration into safe harbor loci for stable cell line generation and large-scale mammalian cell library screening.

3. How-To Guide For TARGATT™ Transgenic Kit 10/3/2025

   The TARGATT™ Kit enables fast, precise site-specific transgenic mice generation, avoiding random insertion issues and ensuring stable gene expression within three months.

4. iPSC Genome Editing Rapid Automated Cell Line Editing (RACE™) 10/3/2025

   Expert genome editing and iPSC services support preclinical development, offering cell line creation, assays, safety assessments, and manufacturing consultation to accelerate IND-filing readiness.

5. Humanized M-NSG PBMC And CD34+ Mouse Models 2023 10/3/2025

   Humanized M-NSG mouse models reconstructed with human PBMCs or CD34+ stem cells offer reliable, ready-to-use tools for infectious disease and immunology research.

6. Human iPSC Modeling, Drug Screening For Neurodegenerative Disorders 10/3/2025

   iPSC technology enables genetically engineered human cells for neurotoxicity and neuroprotection assays, offering scalable disease models for drug discovery and toxicity screening.

7. Second Sourcing Is Natural ... Your Current CDMO Should Understand 9/23/2025

   Seasoned supply chain professionals say it is only natural to de-risk supply chains with sourcing materials and products at more than one external manufacturer ... no matter the insistence from the first external partner.

8. Preclinical Technique To Assess Targeted Therapies For Primary, Metastatic NSCLC 9/13/2025

   To enable comprehensive evaluation of therapies targeting both primary and metastatic tumors, we've developed dual-disease xenograft models using bioluminescence imaging (BLI).

9. Unlock The 3 Keys To Drug Discovery Success — Foresight, Hindsight, And Insight 9/13/2025

   If you don’t know where you are going, how will you get there? Articulating the destination of your therapeutic is essential for determining whether it is commercially viable and meets required milestones.

10. Phenotypic Characterization Of Bleomycin-Induced Pulmonary Fibrosis Mod 9/8/2025

    To gain deeper biological insight, lung injury in this model has been further characterized through cellular phenotyping, gene expression analysis, and cytokine profiling.